Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Current Situation of the Metabolomics Techniques Used for the Metabolism Studies of New Psychoactive Substances.

Manier SK, Meyer MR.

Ther Drug Monit. 2019 Aug 14. doi: 10.1097/FTD.0000000000000694. [Epub ahead of print]

PMID:
31425443
2.

Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding.

Gampfer TM, Richter LHJ, Schäper J, Wagmann L, Meyer MR.

Drug Test Anal. 2019 Aug 19. doi: 10.1002/dta.2683. [Epub ahead of print]

PMID:
31424163
3.

Evaluation of novel organosilane modifications of paper spray mass spectrometry substrates for analyzing polar compounds.

Bambauer TP, Maurer HH, Weber AA, Hannig M, Pütz N, Koch M, Manier SK, Schneider M, Meyer MR.

Talanta. 2019 Nov 1;204:677-684. doi: 10.1016/j.talanta.2019.05.095. Epub 2019 May 26.

PMID:
31357352
4.

Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive Substances.

Manier SK, Niedermeier S, Schäper J, Meyer MR.

J Anal Toxicol. 2019 Jul 26. pii: bkz052. doi: 10.1093/jat/bkz052. [Epub ahead of print]

PMID:
31355413
5.

Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.

Wagmann L, Hempel N, Richter LHJ, Brandt SD, Stratford A, Meyer MR.

Drug Test Anal. 2019 Jul 12. doi: 10.1002/dta.2675. [Epub ahead of print]

PMID:
31299701
6.

Distribution of the (synthetic) cannabinoids JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol following pulmonary administration to pigs.

Schaefer N, Kröll AK, Körbel C, Laschke MW, Menger MD, Maurer HH, Meyer MR, Schmidt PH.

Arch Toxicol. 2019 Jun 21. doi: 10.1007/s00204-019-02493-8. [Epub ahead of print]

PMID:
31227841
7.

Earliest axial fossils from the genus Australopithecus.

Meyer MR, Williams SA.

J Hum Evol. 2019 Jul;132:189-214. doi: 10.1016/j.jhevol.2019.05.004. Epub 2019 May 30.

PMID:
31203847
8.

Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence.

Richter LHJ, Jacobs CM, Mahfoud F, Kindermann I, Böhm M, Meyer MR.

Anal Chim Acta. 2019 Sep 6;1070:69-79. doi: 10.1016/j.aca.2019.04.026. Epub 2019 Apr 15.

PMID:
31103169
9.

Current state of transfusion in traumatic brain injury and associated coagulopathy.

Stolla M, Zhang F, Meyer MR, Zhang J, Dong JF.

Transfusion. 2019 Apr;59(S2):1522-1528. doi: 10.1111/trf.15169.

PMID:
30980753
11.

Sibship, physical activity, and sedentary behavior: a longitudinal, observational study among Mexican-heritage sibling dyads.

Ylitalo KR, Bridges CN, Gutierrez M, Sharkey JR, Meyer MRU.

BMC Public Health. 2019 Feb 14;19(1):191. doi: 10.1186/s12889-019-6521-y.

12.

Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes - A comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvae.

Richter LHJ, Herrmann J, Andreas A, Park YM, Wagmann L, Flockerzi V, Müller R, Meyer MR.

Toxicol Lett. 2019 May 1;305:73-80. doi: 10.1016/j.toxlet.2019.01.010. Epub 2019 Jan 22.

PMID:
30682400
13.

In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.

Wagmann L, Richter LHJ, Kehl T, Wack F, Bergstrand MP, Brandt SD, Stratford A, Maurer HH, Meyer MR.

Anal Bioanal Chem. 2019 Jul;411(19):4751-4763. doi: 10.1007/s00216-018-1558-9. Epub 2019 Jan 7.

PMID:
30617391
14.

Permissive Role of GPER for Arterial Hypertension.

Barton M, Meyer MR.

Hypertension. 2019 Feb;73(2):e9-e10. doi: 10.1161/HYPERTENSIONAHA.118.12159. No abstract available.

PMID:
30595124
15.

HuR-ry Up: How Hydrogen Sulfide Protects Against Atherosclerosis.

Barton M, Meyer MR.

Circulation. 2019 Jan 2;139(1):115-118. doi: 10.1161/CIRCULATIONAHA.118.036854. No abstract available.

PMID:
30592653
16.

Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.

Huber CA, Meyer MR, Steffel J, Blozik E, Reich O, Rosemann T.

Clin Ther. 2019 Jan;41(1):107-117. doi: 10.1016/j.clinthera.2018.11.012. Epub 2018 Dec 24.

PMID:
30591287
17.
18.

Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.

Richter LHJ, Beck A, Flockerzi V, Maurer HH, Meyer MR.

Toxicol Lett. 2019 Feb;301:79-89. doi: 10.1016/j.toxlet.2018.11.007. Epub 2018 Nov 19.

PMID:
30465810
19.

Gender differences in patient and system delay for primary percutaneous coronary intervention: current trends in a Swiss ST-segment elevation myocardial infarction population.

Meyer MR, Bernheim AM, Kurz DJ, O'Sullivan CJ, Tüller D, Zbinden R, Rosemann T, Eberli FR.

Eur Heart J Acute Cardiovasc Care. 2019 Apr;8(3):283-290. doi: 10.1177/2048872618810410. Epub 2018 Nov 8.

PMID:
30406673
20.

Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases.

Wagmann L, Brandt SD, Stratford A, Maurer HH, Meyer MR.

Drug Test Anal. 2019 Feb;11(2):318-324. doi: 10.1002/dta.2494. Epub 2018 Sep 28.

PMID:
30188017
21.

Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot study.

Hahn D, Stokes CS, Kaiser R, Meyer MR, Lammert F, Gruenhage F.

Eur J Clin Invest. 2018 Dec;48(12):e13024. doi: 10.1111/eci.13024. Epub 2018 Sep 19.

PMID:
30175442
22.

Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.

Richter LHJ, Maurer HH, Meyer MR.

Drug Test Anal. 2019 Feb;11(2):305-317. doi: 10.1002/dta.2493. Epub 2018 Oct 9.

PMID:
30160067
23.

Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuse.

Wagmann L, Maurer HH, Meyer MR.

Arch Toxicol. 2018 Sep;92(9):2875-2884. doi: 10.1007/s00204-018-2276-y. Epub 2018 Aug 6.

PMID:
30083819
24.

Can toxicokinetics of (synthetic) cannabinoids in pigs after pulmonary administration be upscaled to humans by allometric techniques?

Schaefer N, Wojtyniak JG, Kroell AK, Koerbel C, Laschke MW, Lehr T, Menger MD, Maurer HH, Meyer MR, Schmidt PH.

Biochem Pharmacol. 2018 Sep;155:403-418. doi: 10.1016/j.bcp.2018.07.029. Epub 2018 Jul 24.

PMID:
30048626
25.
26.
27.

In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.

Pettersson Bergstrand M, Richter LHJ, Maurer HH, Wagmann L, Meyer MR.

Drug Test Anal. 2019 Jan;11(1):45-50. doi: 10.1002/dta.2463. Epub 2018 Aug 9.

PMID:
29996009
28.

Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.

O'Sullivan CJ, Montalbetti M, Zbinden R, Kurz DJ, Bernheim AM, Liew A, Meyer MR, Tüller D, Eberli FR.

Front Cardiovasc Med. 2018 Jun 5;5:63. doi: 10.3389/fcvm.2018.00063. eCollection 2018.

29.

Simple screening tools to identify limited health literacy in a low-income patient population.

Ylitalo KR, Meyer MRU, Lanning BA, During C, Laschober R, Griggs JO.

Medicine (Baltimore). 2018 Mar;97(10):e0110. doi: 10.1097/MD.0000000000010110.

30.

Publisher Correction: A new approach towards biomarker selection in estimation of human exposure to chiral chemicals: a case study of mephedrone.

Castrignanò E, Mardal M, Rydevik A, Miserez B, Ramsey J, Shine T, Pantoș GD, Meyer MR, Kasprzyk-Hordern B.

Sci Rep. 2018 Mar 6;8(1):4295. doi: 10.1038/s41598-018-22367-w.

31.

Neck function in early hominins and suspensory primates: Insights from the uncinate process.

Meyer MR, Woodward C, Tims A, Bastir M.

Am J Phys Anthropol. 2018 Jul;166(3):613-637. doi: 10.1002/ajpa.23448. Epub 2018 Feb 28.

PMID:
29492962
32.

Toxicokinetics of NPS: Update 2017.

Meyer MR.

Handb Exp Pharmacol. 2018;252:441-459. doi: 10.1007/164_2018_102. Review.

PMID:
29476337
33.

Development of an In-vitro Drug Delivery Efficiency Test for a Pulmonary Toxicokinetic Pig Study.

Schaefer N, Kroll AK, Laschke MW, Menger MD, Maurer HH, Meyer MR, Schmidt PH.

Curr Drug Deliv. 2018;15(8):1167-1171. doi: 10.2174/1567201815666180214130014.

PMID:
29446742
34.

Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse.

Manier SK, Richter LHJ, Schäper J, Maurer HH, Meyer MR.

Drug Test Anal. 2018 Jan 4. doi: 10.1002/dta.2355. [Epub ahead of print]

PMID:
29314710
35.

Human cytochrome P450 kinetic studies on six N-2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approach.

Caspar AT, Meyer MR, Maurer HH.

Toxicol Lett. 2018 Mar 15;285:1-8. doi: 10.1016/j.toxlet.2017.12.017. Epub 2017 Dec 23.

PMID:
29277574
36.

Publisher Correction: A new approach towards biomarker selection in estimation of human exposure to chiral chemicals: a case study of mephedrone.

Castrignanò E, Mardal M, Rydevik A, Miserez B, Ramsey J, Shine T, Pantoș GD, Meyer MR, Kasprzyk-Hordern B.

Sci Rep. 2017 Dec 22;7(1):18114. doi: 10.1038/s41598-017-18350-6.

37.

A new approach towards biomarker selection in estimation of human exposure to chiral chemicals: a case study of mephedrone.

Castrignanò E, Mardal M, Rydevik A, Miserez B, Ramsey J, Shine T, Pantoș GD, Meyer MR, Kasprzyk-Hordern B.

Sci Rep. 2017 Nov 2;7(1):13009. doi: 10.1038/s41598-017-12581-3. Erratum in: Sci Rep. 2017 Dec 22;7(1):18114. Sci Rep. 2018 Mar 6;8(1):4295.

38.
40.

Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry.

Caspar AT, Kollas AB, Maurer HH, Meyer MR.

Talanta. 2018 Jan 1;176:635-645. doi: 10.1016/j.talanta.2017.08.063. Epub 2017 Aug 23.

PMID:
28917801
41.

C-terminal phosphorylation of NaV1.5 impairs FGF13-dependent regulation of channel inactivation.

Burel S, Coyan FC, Lorenzini M, Meyer MR, Lichti CF, Brown JH, Loussouarn G, Charpentier F, Nerbonne JM, Townsend RR, Maier LS, Marionneau C.

J Biol Chem. 2017 Oct 20;292(42):17431-17448. doi: 10.1074/jbc.M117.787788. Epub 2017 Sep 7.

45.

Dried urine spots - A novel sampling technique for comprehensive LC-MSn drug screening.

Michely JA, Meyer MR, Maurer HH.

Anal Chim Acta. 2017 Aug 22;982:112-121. doi: 10.1016/j.aca.2017.05.033. Epub 2017 Jun 14.

PMID:
28734350
46.

GPER Mediates Functional Endothelial Aging in Renal Arteries.

Meyer MR, Rosemann T, Barton M, Prossnitz ER.

Pharmacology. 2017;100(3-4):188-193. doi: 10.1159/000478732. Epub 2017 Jul 14.

47.

Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.

Pettersson Bergstrand M, Meyer MR, Beck O, Helander A.

Drug Test Anal. 2018 Mar;10(3):496-506. doi: 10.1002/dta.2243. Epub 2017 Aug 29.

PMID:
28677876
48.

Effect of headless compression screw on construct stability for centre of rotation and angulation-based levelling osteotomy. Biomechanical testing in flexion and torsion.

Meyer MR, Perez MA, Hossain MS, Silverman EB, Fitch RB, Wicker RB.

Vet Comp Orthop Traumatol. 2017 Jul 20;30(4):243-247. doi: 10.3415/VCOT-16-09-0136. Epub 2017 Jun 21.

PMID:
28636055
49.

Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples.

Richter LHJ, Flockerzi V, Maurer HH, Meyer MR.

J Pharm Biomed Anal. 2017 Sep 5;143:32-42. doi: 10.1016/j.jpba.2017.05.028. Epub 2017 May 18.

PMID:
28601767
50.

Investigation of Autophosphorylation Sites of Plant Receptor Kinases and Phosphorylation of Interacting Partners.

Meyer MR, Shah S, Gururaj Rao A.

Methods Mol Biol. 2017;1621:121-130. doi: 10.1007/978-1-4939-7063-6_12.

PMID:
28567649

Supplemental Content

Loading ...
Support Center